RetinalGenix Technologies Inc. (RTGN)
OTCMKTS · Delayed Price · Currency is USD
3.990
0.00 (0.00%)
Oct 20, 2026, 4:00 PM EDT

RetinalGenix Technologies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-2.08-2.42-4.32-2.09-1.88-2.18
Net Income
-2.09-2.43-4.32-2.09-3.91-2.18
Earnings Per Share
-0.11-0.13-0.24-0.12-0.25-0.05
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.030.010.01000
Total Debt
0.490.540.520.510.160.07
Net Cash (Debt)
-0.46-0.53-0.52-0.51-0.16-0.07
Net Cash Growth
------
Net Cash Per Share
-0.02-0.03-0.03-0.03-0.01-0.00

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.48-0.56-0.74-0.45-0.2-1.17
Capital Expenditures
-----0-
Free Cash Flow
-0.48-0.56-0.74-0.45-0.2-1.17
Free Cash Flow Growth
------